PortfoliosLab logoPortfoliosLab logo
ISIN
US7599101026
CUSIP
759910102
IPO Date
Mar 20, 1996

Highlights

Market Cap
$188.78M
Enterprise Value
$183.93M
EPS (TTM)
-$0.05
Total Revenue (TTM)
$43.26M
Gross Profit (TTM)
$25.98M
EBITDA (TTM)
-$1.51M
Year Range
$3.20 - $6.61
Target Price
$7.00
ROA (TTM)
-7.97%
ROE (TTM)
-13.47%
Avg. Volume (1M)
131K
Avg. Volume Value (1M)
$536.52K

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Repro Med Systems, Inc.

Performance

KRMD Performance Chart

Repro Med Systems, Inc. (KRMD) is down 29.3% since the beginning of the year. At $4 per share, KRMD is trading 37.8% below its 52-week high of $7. Investors who bought $1,000 worth of KRMD shares 5 years ago would now be looking at an investment worth $1,205.


Loading charts...

Benchmark

Compare this symbol against anything

Returns By Period

Repro Med Systems, Inc. (KRMD) has returned -29.26% so far this year and 18.10% over the past 12 months. Looking at the last ten years, KRMD has achieved an annualized return of 23.80%, outperforming the S&P 500 Index benchmark, which averaged 13.26% per year.


Repro Med Systems, Inc.

1D
0.00%
1M
-8.46%
6M
-23.75%
YTD
-29.26%
1Y
18.10%
3Y*
17.32%
5Y*
3.80%
10Y*
23.80%
ALL TIME*
11.77%

Benchmark (S&P 500 Index)

1D
0.70%
1M
0.09%
6M
7.94%
YTD
9.41%
1Y
20.07%
3Y*
17.84%
5Y*
11.25%
10Y*
13.26%
ALL TIME*
8.09%
*Multi-year figures are annualized to reflect compound growth (CAGR)

KRMD Monthly Returns History

Based on dividend-adjusted daily data since Mar 20, 1996, KRMD's average daily return is +0.39%, while the average monthly return is +3.82%. At this rate, an investment would double in approximately 1.5 years.

Historically, 47% of months were positive and 53% were negative. The best month was Apr 2003 with a return of +250.0%, while the worst month was Jan 2008 at -52.1%. The longest winning streak lasted 9 consecutive months, and the longest losing streak was 9 months.

On a daily basis, KRMD closed higher 28% of trading days. The best single day was Jul 9, 1999 with a return of +175.0%, while the worst single day was Oct 11, 2007 at -47.4%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-7.23%-11.50%-9.43%-7.64%1.75%3.45%-2.14%-29.26%
202514.03%-21.18%-26.59%8.27%-1.82%32.59%-3.35%21.97%-9.24%3.39%49.49%-1.86%50.91%
2024-15.27%1.92%11.32%-8.05%-1.84%24.41%-12.45%8.62%8.33%6.96%36.30%-3.27%56.82%
202311.48%4.77%1.20%5.92%-18.01%-5.87%-24.64%0.77%3.05%-15.93%-0.44%8.63%-31.23%
20220.33%6.31%-10.62%-7.34%-17.36%15.53%-0.00%-2.37%-9.72%7.62%22.92%21.02%19.00%
2021-32.89%-3.96%-9.28%7.10%13.26%8.43%-26.35%-4.69%-12.31%-12.63%38.15%-12.79%-50.17%

Benchmark Metrics

Repro Med Systems, Inc. has an annualized alpha of 156.17%, beta of 0.34, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since March 20, 1996.

  • This stock participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (63.00%) than losses (39.13%) - typical of diversified or defensive assets.
  • Beta of 0.34 may look defensive, but with R2 of 0.00 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
  • R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
156.17%
Beta
0.34
0.00
Upside Capture
63.00%
Downside Capture
39.13%

Return for Risk

Risk / Return Rank

KRMD ranks 56 for risk / return — above 56% of stocks peers on PortfoliosLab. Its historical combined result is near the middle of the peer group.


KRMD Risk / Return Rank: 5656
Overall Rank
KRMD Sharpe Ratio Rank: 5858
Sharpe Ratio Rank
KRMD Sortino Ratio Rank: 5959
Sortino Ratio Rank
KRMD Omega Ratio Rank: 5555
Omega Ratio Rank
KRMD Calmar Ratio Rank: 5656
Calmar Ratio Rank
KRMD Martin Ratio Rank: 5454
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

Risk / Return Metrics

The table below present risk-adjusted performance metrics for Repro Med Systems, Inc. (KRMD) and compare them to S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


KRMDBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

-1.05

Sortino ratioReturn per unit of downside risk

-0.96

Omega ratioGain probability vs. loss probability

1.11

1.25

-0.15

Calmar ratioReturn relative to maximum drawdown

0.44

2.00

-1.56

Martin ratioReturn relative to average drawdown

0.75

8.49

-7.74

Dividends

Dividend History


Repro Med Systems, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Repro Med Systems, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Repro Med Systems, Inc. was 97.69%, occurring on Apr 3, 2003. Recovery took 3676 trading sessions.

The current Repro Med Systems, Inc. drawdown is 66.91%.


Drawdown

Fall

Recovery

Underwater

Related event

-97.69%Apr 2003
3y 21d14y 7mo
17y 8moMar 2000 - Nov 2017
-84.30%Jun 2022
2y 1mo
6y 3moApr 2020 - now
Bear market2022
-78.67%Feb 1999
1y 3mo11mo 5d
2y 2moOct 1997 - Jan 2000
-48.44%Mar 2020
9d1mo
1mo 9dMar 2020 - Apr 2020
COVID crash2020
-42.86%Mar 2000
7d6d
13dFeb 2000 - Mar 2000
Dot-com crash2000–2002

Drawdown Indicators


KRMDBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-97.69%

-56.78%

-40.91%

Max Drawdown (1Y)

Largest decline over 1 year

-42.79%

-9.10%

-33.69%

Max Drawdown (3Y)

Largest decline over 3 years

-57.96%

-18.90%

-39.06%

Max Drawdown (5Y)

Largest decline over 5 years

-57.96%

-25.43%

-32.53%

Max Drawdown (10Y)

Largest decline over 10 years

-84.30%

-33.92%

-50.38%

Current Drawdown

Current decline from peak

-66.91%

-1.58%

-65.33%

Average Drawdown

Average peak-to-trough decline

-59.17%

-10.70%

-48.47%

Ulcer Index

Depth and duration of drawdowns from previous peaks

25.10%

2.14%

+22.96%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Repro Med Systems, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Repro Med Systems, Inc. is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for KRMD relative to other companies in the Medical Instruments & Supplies industry. Currently, KRMD has a P/S ratio of 4.4. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for KRMD in comparison with other companies in the Medical Instruments & Supplies industry. Currently, KRMD has a P/B value of 11.3. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with KRMD

Add Repro Med Systems, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with KRMD